EPS for Baxter International Inc. (BAX) Expected At $0.58

January 22, 2018 - By Migdalia James

 EPS for Baxter International Inc. (BAX) Expected At $0.58
Investors sentiment increased to 0.97 in 2017 Q3. Its up 0.05, from 0.92 in 2017Q2. It is positive, as 38 investors sold Baxter International Inc. shares while 300 reduced holdings. 76 funds opened positions while 253 raised stakes. 439.80 million shares or 0.96% less from 444.08 million shares in 2017Q2 were reported.
Wetherby Asset Management owns 9,785 shares. Tci Wealth Advsr invested 0.08% in Baxter International Inc. (NYSE:BAX). Art Limited Liability holds 0.01% of its portfolio in Baxter International Inc. (NYSE:BAX) for 4,300 shares. Advsrs Ltd Co reported 102 shares. Systematic Fincl Lp accumulated 0.22% or 175,790 shares. Fin Service Corporation stated it has 11,050 shares or 0.34% of all its holdings. 3,335 were accumulated by Jones Fincl Lllp. Guardian Capital L P holds 90,730 shares or 0.79% of its portfolio. Veritable Lp reported 29,475 shares. Ameriprise Financial Inc invested in 0.24% or 8.20 million shares. John G Ullman & Incorporated holds 99,008 shares or 1.21% of its portfolio. Dorsey Whitney Tru Com Ltd Com holds 0.77% or 61,393 shares. Guardian Life Com Of America owns 0.01% invested in Baxter International Inc. (NYSE:BAX) for 1,138 shares. Efg Asset (Americas) holds 2.01% or 84,689 shares. Allsquare Wealth Mgmt holds 496 shares or 0.03% of its portfolio.

Since August 17, 2017, it had 0 insider purchases, and 4 sales for $2.16 million activity. Another trade for 9,440 shares valued at $583,014 was sold by FORSYTH JOHN D. Another trade for 12,670 shares valued at $772,363 was sold by Accogli Giuseppe. Shapazian Carole J sold 4,020 shares worth $247,672.

Analysts expect Baxter International Inc. (NYSE:BAX) to report $0.58 EPS on February, 7.They anticipate $0.01 EPS change or 1.75 % from last quarter’s $0.57 EPS. BAX’s profit would be $316.01 million giving it 30.18 P/E if the $0.58 EPS is correct. After having $0.64 EPS previously, Baxter International Inc.’s analysts see -9.38 % EPS growth. The stock increased 1.17% or $0.81 during the last trading session, reaching $70.01. About 3.53M shares traded or 27.95% up from the average. Baxter International Inc. (NYSE:BAX) has risen 32.55% since January 22, 2017 and is uptrending. It has outperformed by 15.85% the S&P500.

Baxter International Inc. (NYSE:BAX) Ratings Coverage

Among 18 analysts covering Baxter International (NYSE:BAX), 11 have Buy rating, 0 Sell and 7 Hold. Therefore 61% are positive. Baxter International had 49 analyst reports since July 30, 2015 according to SRatingsIntel. Evercore initiated the stock with “Buy” rating in Wednesday, May 4 report. The stock of Baxter International Inc. (NYSE:BAX) earned “Overweight” rating by Barclays Capital on Thursday, October 26. On Thursday, July 30 the stock rating was downgraded by Leerink Swann to “Market Perform”. On Tuesday, December 12 the stock rating was maintained by BMO Capital Markets with “Buy”. On Thursday, April 14 the stock rating was upgraded by Piper Jaffray to “Overweight”. On Thursday, October 13 the stock rating was initiated by Wells Fargo with “Outperform”. RBC Capital Markets maintained the stock with “Hold” rating in Wednesday, November 22 report. As per Tuesday, April 4, the company rating was upgraded by Leerink Swann. On Thursday, October 26 the stock rating was maintained by Morgan Stanley with “Equal-Weight”. Leerink Swann maintained Baxter International Inc. (NYSE:BAX) on Wednesday, October 28 with “Market Perform” rating.

Baxter International Inc. provides a portfolio of renal and hospital products. The company has market cap of $38.14 billion. The firm operates through two divisions, Hospital Products and Renal. It has a 37.48 P/E ratio. The Hospital Products segment makes intravenous solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products.

More recent Baxter International Inc. (NYSE:BAX) news were published by: Twst.com which released: “Baxter International Inc.: Baxter Expands Voluntary Nationwide Recall to …” on January 16, 2018. Also Businesswire.com published the news titled: “Baxter Announces Agreement to Broaden Portfolio of Innovative Surgical Products” on January 08, 2018. Seekingalpha.com‘s news article titled: “Hospitals still grappling with IV fluid shortage” with publication date: January 18, 2018 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.